Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2026-05-17 @ 5:18 PM
Study NCT ID:
NCT06029257
Status:
RECRUITING
Last Update Posted:
2025-01-29
First Post:
2023-09-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)
Sponsor:
Almirall, S.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CZATCH-2023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None